Exploring lesbian, gay and bisexual patients' accounts of their experiences of cancer care in the UK Despite greater recognition of rights and responsibilities around the care of cancer patients who identify as lesbian, gay or bisexual (LGB) within healthcare systems in the United Kingdom, recent quantitative evidence suggests that they experience poorer care than heterosexual counterparts and qualitative findings are limited. Therefore, in the present study, we present an analysis of the accounts of fifteen British LGB cancer patients (diagnosed with different forms of the disease) of the care received. Data were collected through in-depth individual interviews and analysed using thematic analysis. Three of the emerging themes are discussed. These include an examination of what we conceptualise as the 'awkward choreography around disclosure' opportunities and dilemmas for LGB patients, we describe 'making sense of sub-optimal care' which included instances of overt discrimination but was more frequently manifested through microaggressions and heteronormative systems and practices, and explore accounts of 'alienation from usual psychosocial cancer support'. We employ Meyer's Minority Stress Theory (2003) as a lens to interrogate the data and explore the ways in which actual or anticipated prejudice affected their experiences of treatment and support. We close with recommendations to enhance LGB-affirmative cancer care including enhanced training of healthcare professionals and explicit articulation of institutional commitment to LGB equality.
INTRODUCTION
Across Europe, there is increasing recognition that lesbian, gay or bisexual (LGB) people experience health inequalities including in their access to health services where their care may be compromised and their needs overlooked. The European Fundamental Rights Agency (2012) reported considerable variation in LGB patient experience between countries: one-fifth of lesbians in Sweden and the UK felt personally discriminated against, whereas this was the case for 5% of respondents in Luxembourg and the Netherlands. European research has been mainly conducted in primary care; one of the largest studies worldwide in General Practice suggests that LGB people report worse physical health and poorer care than their heterosexual counterparts (Elliott et al. 2014 ). Yet, while there is a growing number of studies emerging from North American and Australian contexts (e.g. Filiault et al. 2008; Lee et al. 2013; Wassersug et al. 2013; Torbit et al. 2014; Boehmer & Elk 2015; Quinn et al. 2015) , there are very few British or European studies of LGB patients' access to and experiences of cancer care (for exceptions, see Fish 2010, in press; Hill & Holborn 2015) .
Taking the UK as an exemplar in Europe, health policy recognises that inequalities in cancer arising from demographic characteristics including sexual orientation may result in differences between individuals' experience and/ or outcome from cancer (All Party Parliamentary Group on Cancer 2009). Estimating the numbers of people affected by cancer is problematic because the National Cancer Intelligence Network does not collect relevant data; consequently, the prevalence and distribution of cancer in LGB communities is not known. Moreover, there are relatively few health surveys in the UK which include sexual orientation as a demographic variable. The National Survey of Sexual Attitudes and Lifestyles found 2.4% of their survey respondents self-identified as a LGB person suggesting that at least 6000 LGB people are diagnosed with cancer each year (Mercer et al. 2013) .
By contrast to the relative lack of European data, research in the USA reveals that gay men have twofold odds of reporting a cancer diagnosis compared with heterosexual men (Boehmer et al. 2011) . Being HIV positive is a cancer risk factor for both AIDS-associated (Kaposi's sarcoma and non-Hodgkin's lymphoma and invasive cervical cancer) and non-AIDS-associated cancers (lung, vaginal, liver, anal colorectal and renal cancers) (Frisch et al. 2003) . Lesbian and bisexual women breast cancer survivors were twice as likely to report fair or poor health compared with heterosexual women (Boehmer et al. 2011) . This study also revealed that LGB people are diagnosed with cancer at a younger age. A study of cancer survivorship (Boehmer et al. 2011) found that the rate of reporting cervical cancer among bisexual women was more than twice that of other women. Furthermore, women living with a same-sex partner experienced a three times age-adjusted risk of dying from breast cancer than did other women (Cochran & Mays 2012) . A systematic review revealed an absence of UK-published evidence which examines the needs of LGB cancer patients (Hill & Holborn 2015) . The review revealed distinctive experiences in relation to experiences of care, coping and wellbeing, emotional support, body image and sexual function.
Studies suggest that there may be differences in coping with a number of cancers between heterosexuals and sexual minorities and generally greater psychosocial challenges are reported. Sexual minority women were shown to have a more negative outlook about their future health prospects and were more likely to have sought mental health counselling for breast cancer in comparison to heterosexual women (Boehmer et al. 2013) . Using a measure of perceived benefits following a breast cancer diagnosis, researchers found that heterosexual women reported more benefit finding from the illness than did lesbians (Arena et al. 2006) . In a study of health-related quality of life, researchers found worse mental health functioning and greater fear of cancer recurrence among gay and bisexual men with prostate cancer (Hart et al. 2014) . Other research has shown how concerns around body image and sexual behaviour often differ for gay men and lesbians who have experienced prostate or breast cancer compared with heterosexual counterparts (Thomas et al. 2013; Paul et al. 2014) . These studies highlight some differences in the experiences of cancer among LGB people.
The Cancer Patient Experience Survey (CPES) is the flagship UK national assessment of patient satisfaction with cancer treatment; in the absence of other data, it constitutes the most robust evidence of unmet need (CPES 2014) . Among the 67 000 respondents, it found that LGB people report less positive patient experiences, in comparison to heterosexual respondents, in relation to accessible information, psychosocial support, the human rights concerns of dignity and respect and management of pain. The survey, repeated over 4 years suggesting that these are intractable problems, found that LGB patients were more likely to disagree with statements such as they never felt treated as a set of cancer symptoms rather than as a whole person or the doctor did everything they could to manage my pain (Johnson & Fish 2015) . The aim of the CPES is to drive improvements for patients; but because the survey did not include a qualitative component, we do not know about the nature of their access to cancer care or its associated meanings. To address this gap in current knowledge and to inform policy and practice, we carried out this qualitative study which aimed to capture the nature of contemporary cancer care, LGB people's information needs and help-seeking experiences in the UK.
Theoretical and conceptual underpinnings
Experiences of health and healthcare are relatively undertheorised in the social science literature (Wilton 2000) . Minority stress theory (MST) has been developed to explain the everyday heteronormativity experienced by LGB people through an association between stigma, discrimination and mental distress (Meyer 2003) . This conceptual framework includes 'prejudice events, expectations of rejection, hiding and concealing, internalised homophobia and ameliorative coping' (Meyer 2003, p. 674) . Thus, it includes consideration of both the effects of actual and anticipated prejudice and hostility and the strategies that LGB individuals may use around the disclosure or performance of their sexual identity to avoid or deflect conflict and hostility. While such inter-personal events and intra-psychic processes have been shown to be associated with poor mental health (Cook et al. 2014) , little attention has yet been devoted to the impact of such experiences on physical health outcomes (Frost et al. 2015) or how they may influence interactions between LGB individuals and healthcare professionals. Although a number of theories (e.g. Hatzenbuehler 2014) have discussed the impact of social conditions, including stigma and prejudice, on the health and well-being of people from sexual minority groups, there has been only a small body of previous work that has considered how stigma affects LGB cancer care more specifically (e.g. Thomas et al. 2013; Eliason and Dibble 2015) . Partly informed by this theoretical perspective, the study was interested in how participants managed these stress processes during their progress through the cancer pathway.
METHODS

Design
This is one of the first qualitative studies to be conducted among LGB people with any form of cancer in the UK about experiences of cancer care. We adopted some of the principles of participatory research (Baum et al. 2006) to ensure that the study design and analysis reflected the concerns of LGB service users. To this end, a stakeholder group was established which met before the study's inception and then regularly throughout the project. Participants included staff from a local hospice which provides end of life care for LGB people with cancer; representatives from two local voluntary sector agencies; local hospital staff; an academic in nursing; and cancer service users who shared their experiences as patients. The stakeholder group contributed to the project design, including the interview schedule (see Appendix 1), recruitment and data generation and thematic analysis. At the end of the project, a Public Engagement event was held where one of the presentations, led by a carer whose partner had died, provided an intensely personal account with stories and photographs. Afternoon workshops on service user, carers' and trans' perspectives were led by two members of each of those groups to ensure their contributions informed the agenda setting for future research and to increase the impact and use of study findings. A project report has been widely disseminated to cancer charities and other voluntary sector organisations (Fish & Lockley 2015) .
Participants
The inclusion criteria were that participants had been diagnosed with any form of cancer within the past 5 years and self-identified as a lesbian, gay man or bisexual person.
Procedure
The study was funded as a 12-month project by a local cancer charity. Difficulties in recruiting this hidden population have led to innovations in previous research, for example, using an online focus group (e.g. Thomas et al. 2013) . We gave radio interviews and wrote articles for the LGBT press to publicise the study, but together with contact through 50 local mainstream cancer groups, these strategies yielded no potential participants. Drawing on lessons from previous research in sexual minority communities (Fish 1999), we used purposive sampling strategies using a project designed flyer, which gave brief aims of the study, distributed through community-based organisations and social media, which are well established in qualitative research (Carter & Little 2007) . Potential participants contacted the research assistant by mobile phone, email or social media and an initial discussion took place about the aims and purpose of the study. Participants were sent a participant information sheet, provided informed consent and gave brief demographic information before taking part in the study. Six participants were recruited through two support groups for gay and bisexual men with prostate cancer; one participant had set up an online support group for LGBT people with any form of cancer.
Semi-structured interviews lasting between 1 and 2 h took place in a location of participants' choice, mainly their own homes or in university or other private offices, were conducted by an experienced interviewer, whose identity was an older lesbian, between July and December 2014. The interviews were digitally recorded and transcribed verbatim.
Ethics
Ethics approval was given by one of De Montfort University's Health and Life Sciences, Research Ethics Committee in December 2013. The study was conducted in accordance with the British Psychological Society (BPS), Code of Research Ethics (British Psychological Society 2010) . Participants were provided with full information to enable them to take part and we obtained informed consent. To ensure confidentiality and privacy, participants were allocated a pseudonym; a distress protocol was implemented and participants had the right to pause, reconvene or terminate the interview. All data were securely stored and appropriately anonymised.
Thematic analysis
Integrating MST with thematic analysis, two members of the research team undertook immersive readings of the data to generate initial meanings and identify codes. Following Braun and Clarke (2006, p. 82) , our approach to thematic analysis is infused by 'critical realism'; this perspective acknowledges that the way people make meaning of their experiences is constructed through language. It also recognises the ontological and everyday experience of living with cancer while acknowledging that participants' accounts are socially constructed. We paid attention to the meaning-making of participants in an iterative process. At phase 1, two researchers independently read a subset of transcripts; this immersive reading involved the identification of patterns in the data. For example, we noted that participants had different approaches to the management of their sexual orientation and at this early stage, we considered two separate and robust binary categories for disclosure/non-disclosure. We coded these data and identified four distinct ways of managing sexual orientation in cancer care. Subsequently, we accounted for these differences within a more nuanced single overarching theme. At phase 4 of the analysis, we presented a preliminary mapping of the data in six overarching themes to the stakeholder group who vigorously debated the findings and provided context for them. This process helped to clarify some of the key issues in the data. As Braun and Clarke (2006, p. 94) suggest, we asked 'what are the assumptions underpinning the disclosure of their sexual orientation?' and 'what are the implications of participants' uncertainty about interactions with professionals?' We then reviewed the themes, reduced their number to provide a clear focus for this paper and re-named them to refine their specifics and make sure the 'overall story the analysis tells' reflects the data collected (Braun & Clarke 2006, p. 87) .
FINDINGS
Fifteen
LGB people with a cancer diagnosis took part in the study; their demographic characteristics are summarised in Table 1 below. Six lesbians, eight gay men and one bisexual man were interviewed; the sites of the cancers were prostate (7); breast (3); lymphoma (2); skin (1); bowel (1); and ovarian (1). The average age of participants was 54 and average time since diagnosis was 21 months. All participants had undergone treatment for cancer.
For this paper, we have selected three of our themes relating to sexual minority status in cancer care. These are explained below with illustrative verbatim quotations in all cases. We report on dilemmas and difficulties experienced by participants around disclosing their sexuality, negative experiences of care from some healthcare professionals with a focus on heteronormativity, institutional heterosexism and micro-aggressions and accounts of posttreatment support in both clinical and community contexts and how well these resources met the psychosocial needs of the participants. We subsequently discuss our findings in the context of theory, policy and practice in the discussion section.
The awkward choreography of disclosure in LGB cancer care
From close reading of accounts, we found that more of our group of participants were 'out' in their everyday lives than is typical among older LGB people generally. Yet, their narratives suggest they are often pushed back into the closet in cancer care -both in clinical (treatment) and community (survivorship support) contexts. During the interviews, they talked about a range of reasons why they often did not disclose their sexual orientation during their care journey. These included lack of opportunities for disclosure, a belief that disclosure was irrelevant to treatment and survivorship, and a perceived lack of emotional resources to manage anticipated negative reactions. Many participants mentioned how heterosexuality was assumed even if they provided cues around LGB identity. A small number of participants decided to 'take control' of the situation by immediately addressing misconceptions and routinely 'announcing' their sexual orientation when they met professionals:
Well there is no need to be apologetic and I think if you are out front with it, it doesn't give people any cause for ambiguity (Craig, aged 59, prostate cancer).
Most participants expressed a preference for being open about their sexual orientation and sought the reassurance of affirmation. This often led to rather fragmented patterns of disclosure.
I do think that's it's a, it's a matter of feeling comfortable which I think in my own opinion is only by being out. It's a matter of the right environment or to be out, to not have any fears whatsoever of being out in those situations (Noel, aged 69, prostate cancer).
For various reasons, most of our participants did not take the initiative to spontaneously state their sexual orientation. Some participants expected staff to be more attuned to cues around an LGB identity and to open up a conversation. However, this rarely occurred. For example Nathan, who lived in a city known to have a large sexual minority population, mentioned how staff at his hospital 'just assumed I was straight, straightaway' despite him wearing rainbow bracelets. For Quentin, despite the presence of his same-sex partner, staff did not facilitate disclosure:
It's a funny thing because it's almost, there isn't the opportunity in some ways. So [my partner] has been with me to various appointments, picked me up off the chemo suite, and has been in and sat down, and I have not found there is that opportunity, people don't ask. And I am not going to [say] 'hello everybody' (Quentin, aged 56, prostate cancer).
A rather different reason given for non-disclosure occurred in Gertrude's account; she chose not to come out to professionals because she did not think it was relevant: I don't expect someone to say oh I am straight, when you are talking about something else that's nothing to do with it (Gertrude, aged 71, lymphoma).
Gertrude did not want to put herself in a 'category' and preferred to blend: as a cancer patient receiving treatment, she considered herself the same as everyone else and felt that her 'sexuality wasn't an issue'.
Faced with the life-threatening urgency of a cancer diagnosis, several other participants talked about being in survival model where identity and sexuality became less important. Rather, concerns about the possibility of dying meant that they focussed on the medical aspects of treatment for cancer:
It didn't feel at that time it [sexual orientation] was anything that contributed to getting a better diagnosis or a better service. . ...That was because my life is threatened and that's [my sexual orientation] sort of dropped down a number of notches (Norman, aged 52, prostate cancer).
While these data extracts initially seem to simply relate to the participants' asserting the irrelevance of sexual identity in an urgent care context, a deeper analysis of the data demonstrates fears that disclosure might lead to a poorer treatment because of concerns over stigma and discrimination. Some participants anticipated a negative reaction if they did disclose and they did not feel they had the emotional resources or resilience to resist and manage this at a time of sickness and vulnerability (as they would have done when in good health). As alluded to by Noel previously, the perceived psychological safety of disclosure was often judged on an individual-by-individual basis:
Because of the way I'd been treated before the diagnosis I was very, very wary of the place. I knew that the surgeon and the. . .nurse were ok, they weren't hostile at all, but I didn't want to attract anything negative. So it wasn't exactly a conscious decision, it was more don't be completely open I suppose. (Karl, aged 59, prostate cancer)
We have utilised the phrase 'awkward choreography' to highlight both the uneasiness and the planning which precede disclosure in the accounts presented here. Our study only looked at the accounts of patients and a future study might usefully explore what healthcare professionals believe is appropriate care. Despite presenting clues about their sexual orientation (by wearing rainbow bracelets or attending with their partner), staff often did not appear to pick up on these visible signs of identity and participants talked about the difficulty they had in disclosing their sexual orientation directly. Because of the awkwardness that disclosure might generate, some bracketed their identities and either actively or passively concealed their sexual orientation; in addition, some did not disclose because they anticipated a negative reaction or were concerned about receiving sub-optimal care. Such concerns were not illfounded as we elucidate in the second theme.
Making sense of sub-optimal care
Disconcertingly, actual accounts of poor care featured in many of the cancer narratives. As will be illustrated, these ranged from instances of overt heterosexism and homophobia to more subtle forms of discrimination. There were also a number of encounters where participants were unsure how to interpret the behaviour of brusque clinicians and were undecided about whether these interactions were unpleasant because of their sexual identity (and the healthcare professionals' disapproval of it) or the clinicians' disposition or standard 'style' of interacting with all patients.
One of the most overt contexts for heterosexist practice was around the inclusion of same-sex partners in consultations or their recognition as legitimate next of kin. A number of participants described instances where partners were negated or derogated.
Tom was at the bed . . .when the [urology consultant] came . . .as part of his ward round and just asked Tom to leave. Having spoken to other people in the same ward as me with people there-he asked who Tom was, which was ironic as we'd already had that conversation. When you're lying in a hospital bed feeling like crap, and to be treated like that and have my partner dismissed in that way, was just not acceptable (Quentin, aged 56, prostate cancer) However, demeanour that participants found harder to interpret was more common and they often experienced difficulties in making judgements whether apparent rudeness or discomfort was directly related to the healthcare professional's belief or knowledge about their sexual identity. Many talked about reading body language or second guessing the professionals' attitude when they encountered apparently heterosexist assumptions or other indirect forms of disapproval.
For example, instead of an empathic reply to Nathan's recognition of his likely future incontinence as a consequence of treatment for prostate cancer, the consultant was offhand:
I said if the outcome is that I have to wear a pad everyday I'd much rather be here with a life and wearing a pad than not. And his answer was well you won't be saying that in four years' time. . .. And I must admit the first thing that went through my head is. . . do you know? are you saying it because you think I'm gay or not? or is that just your mannerism? (Nathan, aged 43, prostate cancer) When Noel came out to the consultant, instead of the expected advice about the impact of prostate cancer on his sexual relationships, he described a response that might be characterised as a micro-aggression; a physical recoil from him by the consultant:
I sat down and he said oh we've got the [test results], and I said well I want to tell you that I'm a gay man. My main concern, I must admit at that time was all about libido and stuff like that. I got a very bad reaction from him, not verbally, but it obviously was a physical withdrawal, that kind of thing (Noel, aged 69, prostate cancer).
Other participants felt that assumptions were made because of a lack of training of hospital staff who utilised stereotypical understandings of LGB sexual identities and families. Heterosexist norms and systems were often applied routinely without adaptation for non-heterosexual patients. For example, lesbian patients, hair loss following chemotherapy meant that something as apparently simple as a wig fitting could become problematic. The only available hair-styles were long and very feminine and the heteronormativity of the conversation Miranda experienced discussing this with the advisor acted as a barrier; Miranda preferred to forego having a wig rather than return to face such questioning:
But she made a couple of comments about well what your husband might think or something like that. . ..I just said I have got to go, I hated it, I found it very, very, yeah just again stereotypical traditional, yeah I just went. She managed to persuade me, well she didn't persuade me, it was just an easy way of getting out, yes order that, in that colour, and I never went back (Miranda, aged 41, breast cancer).
As previously mentioned, a concern for participants with certain types of cancer (e.g. prostate and breast cancer) was the impact of the disease on their sexual health. Some participants said that consultants were reluctant to discuss anything sexual or they talked about it in a euphemistic manner that was 'over simplified, over sanitised and far too optimistic' (Craig). While a taboo around discussing post-cancer sexuality may also be the case for heterosexual patients, Craig pointed to the need to discuss the specific effects of cancer on gay men's sexual relationships without embarrassment:
The anal intercourse thing particularly is something that I think perhaps a lot of the medical world need to get a grip of. It's not something that has been terribly important in my world but it is for a lot of people. And it's a very important part of their expression (Craig, aged 65, prostate cancer).
Participants discussed a range of unacceptable incidents ranging from overt discrimination to routine application of heterosexist norms and values where there appeared to be no intention to promote equality. It is worth noting that on only one occasion did a participant make a formal complaint about homophobic behaviour and in this situation (Quentin's response to the exclusion of his partner by the urologist), the patient's concerns were both dismissed and trivialised and he was admonished by a senior nurse who called him a 'naughty boy'. Other participants felt obliged to keep details of negative interactions hidden. Noel did not clarify the reason for his request to see a different cancer professional, Nathan expressed his anger at the reaction he received in the car to his father (who had accompanied him to the consultation) rather than lodging a complaint and Miranda did not keep a subsequent appointment.
It must be noted that many of our participants also described interactions that were accepting and affirming of their sexual identities and with many professionals who engaged with their partners and LGB friends in a compassionate manner. Notably, Linda described 'complete acceptance' from the staff who cared for her. However, it was more common for participants to report incidents of both indifferent and empathic care in the same hospitals and wards. Concerns around the appropriateness of standard psychoeducational and psychosocial support were also raised as we discuss in the final theme.
Alienation from usual psychosocial cancer support
Here, we consider the subtle heterosexism of mainstream psychosocial support and subsequently the benefits of participation in LGB-specific cancer support groups reported by those participants who had access to such resources. In addition to receiving informal support from partners, friends or family members, many participants (11) accessed more formal sources of support through cancer self-help groups. These organisations were not perceived as supporting participants' social and sexual selves (and participation did not facilitate disclosure) but catered effectively for the informational needs and medical advice:
I went to just two prostate support groups. I didn't feel comfortable coming out, they were both quite big groups, most of them, the guys take their wives along. . . reasonably useful in just picking up information from people. They have specialists going along, specialists in fatigue and diet and all that kind of stuff (Noel, aged 69, prostate cancer).
These support groups tended to be 'professional' and 'very formal', but did not address their emotional and sexual concerns; several gay men in the sample found both the presence of heterosexual women and having a woman leading the group to be inhibitory:
The guys and the wives were really sweet but I still didn't feel I was getting my needs met I wanted to talk like cock and wanking and, (whispers) we have got the wives here we don't sort of talk about it like that (Norman, aged 52, prostate cancer).
Miranda talked about accessing a breast cancer support group. While its intention was to help women to feel better about themselves, she found the activities off-putting and felt she did not belong in what she labelled a 'girly group': It all revolves around how to apply your mascara and how to put your eyebrow pencil on and that kind of stuff. I don't feel like those things apply to me I suppose really, it's just the kind of person I am . . .They are very much based around traditional femininity as to their sessions or ways to make you feel better about yourself, how to deal with your nails and that kind of stuff (Miranda, aged 41, breast cancer).
Relatedly, Toni found the literature around breast cancer survivorship as 'a bit sort of mono, not very diverse' and while she was offered 12 free massage sessions at a breast cancer charity, she only chose to attend for two describing the environment as 'very pink and fluffy'.
Many participants sought information, education and support from LGBT agencies. However, at the time of writing, in the UK voluntary sector, LGB-specific cancer support continues to be limited, with only three face to face support groups for gay and bisexual men with prostate cancer (all in large urban areas) and some online support through charity forums or international groups. In the absence of more focussed support, being signposted to a mainstream cancer support group was not always perceived to be helpful: So I think it's all very well telling LGBT people that they can go to a support group or they can do this or they can do that but when they get there, or when they read something, it's geared up for a straight person so the information they're getting is probably not relevant (Karl, aged 59, prostate cancer). Two gay male participants described setting up separate groups specifically for LGB people with cancer; moreover, six participants described attending a targeted group. One of the participants had initially set up a group for any man with prostate cancer but the heterosexual men in the group had told him that certain topics were off limits for conversation. However in the group for gay and bisexual men, he says:
I can go oh bloody hell you know what it's like when you really want to pick up a bloke and you want to do this and you want to do that. I love coming to this group because I can just talk the way that it is (Norman, aged 52, prostate cancer).
Another participant who attended the group made a similar observation:
It's definitely edgier and people feel able to talk about absolutely anything whereas the other group was not at all like that (Timothy, aged 65, prostate cancer) Participants talked about targeted groups providing them with emotional support, helping each other to deal with family problems and functioning as safe spaces to discuss the impact of prostate cancer on their sexual relationships. Some participants continued to attend both mainstream groups and gay and bisexual men's support groups. Some described mainstream support groups as well-resourced both in terms of staffing and information, but they generally did not meet their emotional support needs: at times they inhibited open discussion of their sexual concerns and, at others, they were seen to be dominated by heteronormative discourses and imagery.
DISCUSSION
Minority stress theory is widely acknowledged as a useful framework for understanding the impact of stigma and discrimination on mental health among LGB communities. Recent studies have turned attention to the deleterious effects of stressful life events on physical health (e.g. Frost et al. 2015) ; this study contributes to the nascent literature by examining the nature of stressful events during cancer care. While stress is believed to have the capacity to induce somatic illness (Dohrenwend 2000) ; in this paper, we argue that 'prejudice events', 'expectations of rejection' and 'hiding and concealing' (Meyer 2003, pp. 10-12) may mediate how cancer care is experienced.
Participants' accounts provide several examples of these three concepts: prejudice events included physical withdrawal and offhand responses; participants' expectations of rejection meant that they moderated their behaviour, in many instances, by concealing their sexual orientation. MST helped to understand these experiences of stigma, which were often nuanced and mundane; participants' accounts were often characterised by apprehension about the disclosure of their identities and uncertainty about cancer professionals' responses should this become known. The subtlety of the interactions, and their preference to keep their identities hidden, might explain why previous research has de-emphasised the influence of sexual minority status in cancer care (Boehmer & White 2012) .
A fourth concept, included in the MST model, is that of internalised homophobia. In psychological models of identity formation (e.g. Cass 1979), the achievement of an integrated sense of self is often associated with the highest level of self-actualisation; by contrast, bracketing the self is seen as a form of evaluative compartmentalisation (Showers & Zeigler-Hill 2007) . Examples of this compartmentalisation include Norman's observation that because his life was threatened by cancer, his sexual orientation 'dropped down a number of notches'; while Tracy says that her medical treatment took priority above her sexual identity as lesbian. By compartmentalising their identities in this way, LGB cancer patients may be inadvertently contributing to the notion that their identities have little or no relevance in healthcare. The concept of relevance also features in health professionals' accounts where the majority of those interviewed in a recent study, did not believe that sexual orientation has relevance for healthcare (Somerville 2015) . This bracketing of identities disrupts the notion of holistic care. An alternative reading of these behaviours is that they are pragmatic responses to achieving the goal of the best possible care in the face of a life-threatening illness, but the impact of concealing part of one's identity may form a cognitive burden. In addition, internalised homophobia is sometimes related to difficulties in 'intimate relationships and sexual functioning' (Meyer 2003, p. 14) , both of which may be associated with a diagnosis of breast or prostate cancer. None of the participants in this study, however, appeared to articulate the negative social attitudes towards themselves or their relationships that are commonly associated with internalised homophobia (Williamson 2000) .
Ameliorative coping strategies form the fifth concept underpinning MST theory. Participants deployed different forms of 'stigma evasion' strategies to cope with prejudice and rejection (Troiden 1989, p. 62) . Tracy describes her approach to accessing care using military and combative metaphors: her 'defences were up'; she responds to suboptimal care by going on the 'offensive'; her partner comes down on poor care like a 'ton of bricks'. Tracy's narrative lends support for MST -which recognises the excess stress that people from stigmatised groups are exposed to -as she describes her experience of discriminatory attitudes as a 'huge barrier of an extra tension'.
In his exposition of the conceptual framework underpinning MST, Meyer (2003) argues that there are three conditions which differentiate MST from the stress experienced by those who are not members of minority groups; these stressors are (1) unique, (2) chronic and (3) socially based. Participants described instances of micro-aggression (Sue 2010) which are unique to their membership of a sexual minority group. The chronic instances of derogation towards participants' partners are indicative of social and structural discrimination which may not be wholly accounted for by MST. Heteronormative assumptions mean that partners were often referred to as friends or siblings, despite the legal recognition afforded, almost a decade prior to the fieldwork, by the Civil Partnerships Act 2004. The devaluation of same-sex relationships relies on social structures and institutions that are beyond individual circumstances; instead, they are based in societal arrangements which privilege heterosexuality.
Minority stress theory has provided a useful lens for interrogating the nature of some poor experiences of cancer care, but there were also many examples of life-enhancing care reported by participants in this study. Holistic notions of health recognise inter-connections between mental and physical health and social well-being. Thus being an LGB patient is not an inconvenient distraction from the treatment of cancer as a disease, but rather, for many, is an integral part of their identity. Positive interactions, which see the person in context, are therefore 'crucial' for the development of well-being (Meyer 2003, p. 4) . Disclosure of sexual orientation to health professionals contributes to improved patient experience in primary care (e.g. McNair & Hegarty 2010); however, in those settings, patients may have opportunity to change their health professional. By contrast, patients with cancer may comprise a vulnerable population as they face a potentially life-threatening condition where treatment is provided within tight timescales often necessitating multiple interactions with healthcare professionals. Some of the participants felt that 'being out' was fundamental to quality care where cancer professionals actively create an environment in which it is safe to disclose, if the patient wishes to do so; moreover, quality care means that professionals are able to discuss the impact of cancer treatment on sexual relationships without embarrassment or discomfort.
The theory provides a conceptual framework for the first two themes identified in the study; however, the theory is less able to provide an explanation for the structural dimensions of the third theme: alienation from usual psychosocial cancer support. The delivery of formal support to cancer patients by hospitals or charities is intended to promote well-being or recovery. These groups are often well-resourced with guest speakers who are oncologists or from other specialties. Yet participants' were not able to express their emotional and sexual concerns in support groups finding the presence of heterosexual women inhibited their conversations. In a similar vein, lesbian and bisexual women felt alienated by the emphasis on traditional notions of femininity in breast cancer support groups. As one of the participants observed, sexual minorities fill in the gap because they do not rely on usual forms of support. This theme highlights the need for equitable cancer support and for personalised services which take account of individual need.
Strengths and limitations
This study has some limitations. Because of the challenges in identifying and recruiting older LGB people with cancer, we are likely to have recruited participants who were more likely to be open about their sexual orientation and involved in LGB cancer support systems. Participants' ages ranged from 41 to 71 and this is a younger sample than is typical of cancer patients. Despite concerted efforts, we were unable to recruit trans patients with cancer: this omission is being addressed in subsequent work. Nor does the sample reflect the ethnic diversity of LGB communities in the UK. Twelve participants (of 15) in this study were partnered; however, research suggests that LGB older people are more likely to live alone (Guasp 2011) . The presence of a partner at an oncology consultation may facilitate disclosure if the patient clarifies their relationship. A partner may also provide the emotional support which could facilitate disclosure. Although this study did not aim to generalise its findings, a sample of 12 partnered participants may not reflect wider LGB communities who may be less able or likely to 'come out'.
The strengths of this study lie in the congruence between its methodology theoretical framework and data analysis; this congruence is a hallmark of rigorous qualitative research (Carter & Little 2007) . The study adopted participatory methods bringing together professionals practising at different stages of the cancer pathway alongside cancer service users in a stakeholder group which provided a safe forum for lively debate. It enabled discussion between providers, some of whom did not perceive the relevance of sexual orientation to cancer care, and service users. Thus, service users were not only engaged in generating data but also actively contributed to the elaboration of wider meanings. In addition, by including narratives where sexual orientation was perceived to be irrelevant to healthcare, we sought to avoid homogenising participants' experiences in our analyses.
We believe that MST provides a useful conceptual framework for understanding the impact of stigma and discrimination on LGB people's experiences of cancer care and reveal the strategies that they adopt to manage stigma: the theory enables the positioning of the person in context and sees people as more than just their disease. The study was not intended for statistical generalisability, but to bring novel and deeper insights into hidden experiences of cancer care. The study's findings about the nature of interactions with professionals may have relevance for future research across secondary tier healthcare where patients attend for the management of other chronic conditions. The findings may also be contextually transferable to other jurisdictions concerned with fundamental rights in Europe, including experiences of stigma in access to healthcare for LGB people.
Conclusion and recommendations
Our findings provide some illustrations of the why, how and when of sexual orientation disclosure and may raise awareness among cancer professionals about the health benefits, potential contribution to improved patient experience and the supportive behaviours which may facilitate it. In the strategy, Achieving World Class Cancer Outcomes, the UK government (Department of Health 2015) has endorsed a set of value standards for ensuring equitable health outcomes. These standards identify 'moments that matter' in the care relationship which embody respect and dignity for cancer patients and are transferrable to international contexts of cancer care. Professionals often do not know how or when to facilitate disclosure, the study findings highlight 'moments that matter' for LGB cancer patients and these are occasions when decisions about disclosure may occur (Table 2 below). Recognising these 'moments that matter' may enable cancer professionals to facilitate disclosure and the study recommends their inclusion in values standards.
Second, the findings point to the importance of creating a holistic care environment; participants noted that there was no reference anywhere in the hospital to the LGB patient experience. Steps to promote inclusion may entail a diversity policy statement, imagery on walls or the display of a LGB staff network on a hospital notice-board. These cancer narratives also highlight the need for LGB cancer support groups and tailored resources. The lack of LGB support groups in the UK mean that some participants were coping with their cancer with few forms of social and emotional support and they found few sources of information which addressed their concerns. The provision of relevant LGB cancer patient information materials, apart from prostate cancer, is currently not available within the NHS.
Finally, our findings suggest that participants had heterogeneous expectations of cancer care requiring complex skills from professionals. Yet studies have shown there is little or no curricula content in university programmes of Medicine or Nursing (McNair & Hegarty 2010) . This might suggest a lack of recognition of distinctive cancer care needs and may explain why participants reported different patient experiences even within the same hospital. The Table 2 . 'Moments that matter' where sexual orientation may become visible Completing the pre-assessment form about next of kin Being called from the waiting room in to the clinic (e.g. Mr and
Mrs Jones) In the consultation room for the initial diagnosis Being present as a couple together at any point in the cancer pathway During the time it takes to push a wheelchair to the operating theatre Being fitted for a wig following chemotherapy Just filling in time having conversations about topics not related to cancer: people draw on their personal lives to initiate or sustain conversation with professionals or other patients Being able to discuss the emotional impact of cancer with a professional If a patient wishes to 'proactively' address concerns, e.g. the impact of prostate cancer treatment on a gay man's sexual relationship/s During visiting times when a partner or a group of same-sex friends visit the ward Accessing other sources of formal or informal support, e.g. through information resources or cancer support groups Discussing personal circumstances (e.g. with Macmillan staff or a welfare rights adviser) to assess benefit entitlements inclusion of LGB research to inform understanding of patient experience, psychosocial concerns and cancer risk is urgently needed in health curricula.
